DERM Scorecard | Journey Medical Corp

Journey Medical Corp (DERM) Scorecard

2026-Q2: Total return Win; Revenue growth Win; EPS growth Lose.
2026-Q1: Total return Lose; Revenue growth Win; EPS growth Lose.
2025-Q4: Total return Win; Revenue growth Win; EPS growth Lose.
2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.

40 QUARTERS × 3 ROAST BATTLES

19/120 All 120 Win/Lose results shown below

Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

Trailing 1 year (4 quarters): 5 wins, 7 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

Quarter	Total return	Revenue growth	EPS growth
2026-Q22/3	WinDERM / S&P 50.96% / 15.20%	WinDERM / S&P 20.68% / 15.00%	LoseDERM / S&P -42.11% / 50.40%
2026-Q11/3	LoseDERM / S&P -39.17% / -4.33%	WinDERM / S&P 15.89% / 11.30%	LoseDERM / S&P -5.13% / 27.70%
2025-Q42/3	WinDERM / S&P 8.29% / 2.65%	WinDERM / S&P 11.07% / 9.00%	LoseDERM / S&P -36.49% / 13.40%
2025-Q30/3	LoseDERM / S&P -0.84% / 8.12%	LoseDERM / S&P 0.04% / 4.61%	LoseDERM / S&P -62.77% / 13.45%
2025-Q22/3	WinDERM / S&P 21.69% / 10.94%	LoseDERM / S&P -5.18% / 4.83%	WinDERM / S&P 1800.00% / 10.63%
2025-Q12/3	WinDERM / S&P 50.90% / -4.27%	LoseDERM / S&P -8.73% / 4.98%	WinDERM / S&P 25.81% / 10.57%
2024-Q41/3	LoseDERM / S&P -30.80% / 2.41%	LoseDERM / S&P -7.59% / 5.25%	WinDERM / S&P 111.43% / 6.15%
2024-Q31/3	LoseDERM / S&P 0.18% / 5.89%	LoseDERM / S&P -4.24% / 5.89%	WinDERM / S&P 13.25% / 6.11%
2024-Q21/3	WinDERM / S&P 53.26% / 4.28%	LoseDERM / S&P -4.37% / 5.38%	LoseDERM / S&P -99.09% / 5.12%
2024-Q10/3	LoseDERM / S&P -36.11% / 10.56%	LoseDERM / S&P -2.95% / 5.71%	LoseDERM / S&P -85.71% / 5.59%
2023-Q41/3	WinDERM / S&P 110.22% / 11.69%	LoseDERM / S&P -15.96% / 6.81%	LoseDERM / S&P -79.17% / 7.78%
2023-Q31/3	WinDERM / S&P 72.33% / -3.27%	LoseDERM / S&P -16.90% / 7.52%	LoseDERM / S&P -72.05% / -5.03%
2023-Q20/3	LoseDERM / S&P 1.27% / 8.74%	LoseDERM / S&P -19.79% / 9.50%	LoseDERM / S&P -38.20% / -8.57%
2023-Q10/3	LoseDERM / S&P -18.23% / 7.50%	LoseDERM / S&P -14.82% / 10.77%	LoseDERM / S&P -51.02% / -15.69%
2022-Q41/3	LoseDERM / S&P -21.95% / 7.56%	WinDERM / S&P 12.45% / 11.88%	LoseDERM / S&P -61.20% / -17.99%
2022-Q32/3	LoseDERM / S&P -34.22% / -4.88%	WinDERM / S&P 22.33% / 13.47%	WinDERM / S&P 34.39% / -1.41%
2022-Q22/3	LoseDERM / S&P -22.57% / -16.10%	WinDERM / S&P 54.87% / 13.71%	WinDERM / S&P 239.05% / 11.04%
2022-Q10/3	LoseDERM / S&P -10.22% / -4.60%	LoseDERM / S&P DERM unavailable / 15.97%	LoseDERM / S&P DERM unavailable / 42.23%
2021-Q40/3	LoseDERM / S&P DERM unavailable / 11.03%	LoseDERM / S&P DERM unavailable / 15.00%	LoseDERM / S&P DERM unavailable / 96.40%
2021-Q30/3	LoseDERM / S&P DERM unavailable / 0.58%	LoseDERM / S&P DERM unavailable / 10.77%	LoseDERM / S&P DERM unavailable / 69.42%
2021-Q20/3	LoseDERM / S&P DERM unavailable / 8.55%	LoseDERM / S&P DERM unavailable / 6.58%	LoseDERM / S&P DERM unavailable / 51.81%
2021-Q10/3	LoseDERM / S&P DERM unavailable / 6.17%	LoseDERM / S&P DERM unavailable / -1.06%	LoseDERM / S&P DERM unavailable / 7.39%
2020-Q40/3	LoseDERM / S&P DERM unavailable / 12.15%	LoseDERM / S&P DERM unavailable / -3.72%	LoseDERM / S&P DERM unavailable / -33.42%
2020-Q30/3	LoseDERM / S&P DERM unavailable / 8.93%	LoseDERM / S&P DERM unavailable / -2.04%	LoseDERM / S&P DERM unavailable / -27.10%
2020-Q20/3	LoseDERM / S&P DERM unavailable / 20.54%	LoseDERM / S&P DERM unavailable / -0.46%	LoseDERM / S&P DERM unavailable / -27.11%
2020-Q10/3	LoseDERM / S&P DERM unavailable / -19.60%	LoseDERM / S&P DERM unavailable / 3.47%	LoseDERM / S&P DERM unavailable / -14.75%
2019-Q40/3	LoseDERM / S&P DERM unavailable / 9.07%	LoseDERM / S&P DERM unavailable / 5.36%	LoseDERM / S&P DERM unavailable / 2.99%
2019-Q30/3	LoseDERM / S&P DERM unavailable / 1.70%	LoseDERM / S&P DERM unavailable / 5.02%	LoseDERM / S&P DERM unavailable / 0.21%
2019-Q20/3	LoseDERM / S&P DERM unavailable / 4.30%	LoseDERM / S&P DERM unavailable / 6.64%	LoseDERM / S&P DERM unavailable / 8.65%
2019-Q10/3	LoseDERM / S&P DERM unavailable / 13.65%	LoseDERM / S&P DERM unavailable / 8.12%	LoseDERM / S&P DERM unavailable / 14.29%
2018-Q40/3	LoseDERM / S&P DERM unavailable / -13.52%	LoseDERM / S&P DERM unavailable / 9.05%	LoseDERM / S&P DERM unavailable / 18.23%
2018-Q30/3	LoseDERM / S&P DERM unavailable / 7.71%	LoseDERM / S&P DERM unavailable / 10.21%	LoseDERM / S&P DERM unavailable / 19.06%
2018-Q20/3	LoseDERM / S&P DERM unavailable / 3.43%	LoseDERM / S&P DERM unavailable / 9.03%	LoseDERM / S&P DERM unavailable / 14.46%
2018-Q10/3	LoseDERM / S&P DERM unavailable / -0.76%	LoseDERM / S&P DERM unavailable / 7.68%	LoseDERM / S&P DERM unavailable / 12.46%
2017-Q40/3	LoseDERM / S&P DERM unavailable / 6.64%	LoseDERM / S&P DERM unavailable / 7.03%	LoseDERM / S&P DERM unavailable / 13.82%
2017-Q30/3	LoseDERM / S&P DERM unavailable / 4.48%	LoseDERM / S&P DERM unavailable / 5.68%	LoseDERM / S&P DERM unavailable / 17.57%
2017-Q20/3	LoseDERM / S&P DERM unavailable / 3.09%	LoseDERM / S&P DERM unavailable / 4.83%	LoseDERM / S&P DERM unavailable / 17.74%
2017-Q10/3	LoseDERM / S&P DERM unavailable / 6.07%	LoseDERM / S&P DERM unavailable / 3.67%	LoseDERM / S&P DERM unavailable / 13.32%
2016-Q40/3	LoseDERM / S&P DERM unavailable / 3.82%	LoseDERM / S&P DERM unavailable / 2.09%	LoseDERM / S&P DERM unavailable / 7.05%
2016-Q30/3	LoseDERM / S&P DERM unavailable / 3.85%	LoseDERM / S&P DERM unavailable / 0.20%	LoseDERM / S&P DERM unavailable / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-27

Metric	DERM total return	S&P 500 Total Return Index
Total return	4.44%	20.78%
Annualized return	4.44%	20.78%

5Y · 2021-11-12 to 2026-08-27

Metric	DERM total return	S&P 500 Total Return Index
Total return	-23.94%	83.14%
Annualized return	-5.33%	12.86%

10Y · 2021-11-12 to 2026-08-27

Metric	DERM total return	S&P 500 Total Return Index
Total return	-23.94%	319.30%
Annualized return	-2.70%	15.41%

Calculation rules

window: Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis: Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule: Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency: Quarter endpoints only.
fundamentals: Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.